صنعتی کیمیدارو
دکیمی | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Income Statement
AGM
Interim
2026/04/20 Fiscal Year 2025/12/2112 Month | 2025/04/09 Fiscal Year 2024/12/2012 Month | 2024/04/03 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 10.162 Trillion | 6.925 Trillion | 7.71 Trillion | |
Total Revenues | 10.162 Trillion | 6.925 Trillion | 7.71 Trillion | |
Cost of Goods Sold | 7.276 Trillion | 5.115 Trillion | 5.438 Trillion | |
Gross Profit | 2.885 Trillion | 1.81 Trillion | 2.272 Trillion | |
General & Administrative Expenses | 1.133 Trillion | 912.001 Billion | 358.701 Billion | |
Net Operating Income & Expenses | 47.15 Billion | 27.674 Billion | -35.974 Billion | |
Operating Profit (Loss) | 1.799 Trillion | 925.876 Billion | 1.877 Trillion | |
Profit Before Tax | 996.247 Billion | 82.201 Billion | 1.396 Trillion | |
Tax | 44.767 Billion | - | 157.574 Billion | |
Net Profit (Loss) After Tax | 951.48 Billion | 82.201 Billion | 1.238 Trillion | |
Retained Earnings at Beginning of Period | 1.021 Trillion | 1.802 Trillion | 2.956 Trillion | |
Approved Dividends — Prior Year AGM | - | -864 Billion | -1.382 Trillion | |
Transfer from Other Equity Items | -13.363 Billion | - | - | |
Allocable Profit | 1.959 Trillion | 1.021 Trillion | 2.812 Trillion | |
Approved Dividends — Current Year | 576 Billion | - | 864 Billion | |
Retained Earnings at End of Period | 1.383 Trillion | 1.021 Trillion | 1.948 Trillion |